Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: paclitaxel|DRUG: Iniparib (SAR2405550 -BSI-201)
Sponsor: Sanofi
Collaborators: SOLTI Breast Cancer Research Group